Autism spectrum disorder management sales will grow through 2036, led by behavioural approaches at a 59.0% share in 2026 as the leading treatment segment. The market is expected to reach USD 2.5 billion in 2026 and USD 4.1 billion by 2036, creating an absolute opportunity of USD 1.67 billion.